abrdn Life Sciences Investors (NYSE: HQL)
$13.4500
+0.1700 ( +0.07% ) 98.0K
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It investsĀ in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
Market Data
Open
$13.4500
Previous close
$13.2800
Volume
98.0K
Market cap
$378.13M
Day range
$13.3150 - $13.6690
52 week range
$12.7600 - $15.8999
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Dec 20, 2024 |
3 | Insider transactions | 2 | Dec 20, 2024 |
n-cen | Other | 5 | Dec 16, 2024 |
n-csr | Other | 17 | Dec 09, 2024 |
nport-p | Other | 1 | Nov 27, 2024 |
n-px | Other | 2 | Sep 03, 2024 |
nport-p | Other | 2 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 27, 2024 |
4 | Insider transactions | 1 | Jul 18, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |